Ga direct naar de inhoud

Ga direct naar de navigatie

Uitgave van

Archief voor de categorie ‘Productontwikkeling’

AstraZeneca and Takeda establish collaboration to develop and commercialise MEDI1341 for Parkinson’s disease

AstraZeneca and Takeda Pharmaceutical Company Limited today announced that they have entered an agreement to jointly develop and commercialise MEDI1341, an alpha-synuclein antibody currently in development as a potential treatment for Parkinson’s disease (PD). Alpha-synuclein (α-synuclein) is an aggregation-prone protein that contributes to the development of PD.

Bron: World Pharma News Meer lezen »

Nederlandse anti-malaria drones worden ingezet in Kenia

Een aantal Nederlanders hebben de handen ineen geslagen voor het Anti Malaria Drones project. De naam zegt het al, met behulp van drones willen ze deze strijd aangaan met deze ziekte. En middels een crowdfunding-campagne kan ook jij deelnemen aan dit initiatief.

Bron: World Pharma News Meer lezen »

AstraZeneca CEO warns of ‘substantial setback’ if new drug fails

AstraZeneca will face a “substantial setback” if its most ambitious foray into cutting edge immunotherapy falls flat, its chief executive Pascal Soriot has acknowledged. The eagerly awaited study into a new lung cancer drug is expected to produce its first results within weeks.

Bron: The Financial Times Meer lezen »

Roche, Boehringer tout new IPF analyses to boost their rival medications

The idiopathic pulmonary fibrosis market-share battle between Roche’s Esbriet and Boehringer Ingelheim’s Ofev hasn’t let up since the FDA green-lighted the medications in October, 2014. And this week, both drugmakers upped the ante with positive new data for their contenders.

Bron: FiercePharma Meer lezen »

J&J fires off legal salvo to block Samsung’s Remicade biosim launch

Dead set on defending its top drug, Johnson & Johnson is taking South Korea’s Samsung Bioepis to federal court on claims the latter company is violating Remicade patents and refusing to participate in an established patent dispute resolution process.

Bron: FiercePharma Meer lezen »

Onderzoek met dieren. Kan het ook anders?

Op dit moment is hij de enige hoogleraar Proefdierwetenschappen in Nederland. Prof. Jan-Bas Prins zet in op onderwijs, onderzoek en open communicatie over onderzoek met dieren. Het welzijn van de dieren en vervangen van dierproeven vindt hij minstens zo belangrijk. ‘Niemand is voorstander van dierproeven, ook ik niet.’

Bron: Medicalfacts Meer lezen »

Chilean pharmacies begin marijuana medicine sales in first for Latam

Pharmacies in Chile’s capital Santiago will start selling cannabis-based medicines this week, the first time such treatments have been offered by drug stores in Latin America, the companies behind the launch said on Wednesday. Canadian cannabis producer and distributor Tilray said it had partnered with local firm Alef Biotechnology, which is licensed by the Chilean […]

Bron: Reuters Meer lezen »

Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town

AstraZeneca’s Imfinzi won its bladder cancer approval just last week—but it’s no longer the newest immuno-oncology med for the condition. Pfizer and Merck KGaA’s Bavencio (avelumab) nabbed its own accelerated FDA OK on Tuesday, with the advanced or metastatic urothelial carcinoma nod marking its second indication overall.

Bron: FiercePharma Meer lezen »

Walmsley suggests GSK needs bigger product launches

Just a few years ago industry observers were talking about the death of the blockbuster model, but it seems it is still very much alive and well in pharma. In fact, GlaxoSmithKline’s new chief executive Emma Walmsley says that focusing on big brands will be the driver for the firm’s R&D efforts in the coming […]

Bron: PMLiVE Meer lezen »

Nieuw antibioticaplatform gelanceerd

Dinsdag 18 april is in Utrecht het Netherlands Antibiotic Development Platform (NADP) gelanceerd. Het initiatief moet onderzoek naar nieuwe antibiotica stimuleren. Het NADP streeft naar de ontwikkeling van meer nieuwe antibiotica en alternatieve therapieën voor infectieziekten. Dit geldt voor zowel mensen als dieren.

Bron: Medicalfacts Meer lezen »

« Oudere artikelen |